Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

A symposium organised by the Nuffield Department of Population Health to mark the 60th anniversary of the Hinchliffe Report - by a government committee which examined the rise in pharmaceutical expenditure following the introduction of the NHS.  The report's far-reaching recommendations include:    

  • Improvements in the training of GPs to understand evidence regarding the use of new drugs and the economics of prescribing 
  • Routinely conducting clinical trials to assess drugs and to publish results in an independent prescribers’ journal   
  • Development of an expert body that would be informed by research on economic and social aspects of the NHS
  • An examination of the economics of drug development, marketing and pharmacy to ensure efficiency and equity in prescribing. 

The workshop will reflect on the degree to which we face similar challenges today, and the extent to which these challenges have been addresed. It will also consider whether if a report to look at pharmaceutical expenditure today were to be commissioned, what potential long-term recommendations could be made to address current challenges.

CONFIRMED SPEAKERS INCLUDE    

  • Dr Amanda Adler, Chair of NICE Appraisal Committee and Consultant Physician     
  • Prof Louise Bowman, Professor of Medicine and Clinical Trials, Clinical Trials at the Clinical Trial Service Unit, Nuffield Department of Population Health, University of Oxford      
  • Prof Philip Clarke, Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford        
  • Prof Sir Rory Collins, Head of Nuffield Department of Population Health and BFH Professor of Medicine and Epidemiology     
  • Sir Andrew Dillon, CEO, National Institute for Health and Care Excellence        
  • Dr Elaine Kelly, Senior Research Economist, Institute of Fiscal Studies and the Health Foundation        
  • Prof Martin Landray, Big Data Institute, Nuffield Department of Population Health, University of Oxford        
  • Mr Danny Palnoch, Head of Medicines Analysis, Strategy and Policy, NHS England        
  • Prof Adrian Towse, Office of Health Economics     
The conference will be followed by a drinks reception from 17.00 - 18.00.

 

Forthcoming events

Richard Doll Seminar: Design and analysis of prevalence surveys in low-resource settings

Tuesday, 25 February 2020, 1pm to 2pm @ Richard Doll Lecture Theatre, Richard Doll Building, Old Road Campus, OX3 7LF

WEH/Ethox Seminar

Wednesday, 26 February 2020, 11am to 12.30pm @ Seminar room 0, Big Data Institute, Old Road Campus, OX3 7LF

HERC Seminar: Learning healthcare systems for cost-effective precision oncology.

Thursday, 27 February 2020, 12pm to 1pm @ Seminar room 0, Big Data Institute, Old Road Campus, OX3 7LF

The Global Response to the Novel Coronavirus (SARS-CoV-2) Outbreak

Thursday, 27 February 2020, 2.30pm to 4pm @ Seminar rooms, Big Data Institute

Richard Doll Seminar: The Risk of Everything – using linked electronic health records to develop and validate risk prediction tools for use in clinical care

Tuesday, 03 March 2020, 1pm to 2pm @ Richard Doll Lecture Theatre, Richard Doll Building, Old Road Campus, OX3 7LF

WEH/Ethox Seminar: Building research capacity through North-South Partnerships: some ethical reflections and a social justice agenda

Wednesday, 04 March 2020, 11am to 12.30pm @ Seminar room 0, Big Data Institute, Old Road Campus, OX3 7LF